XBiotech USA, Inc. Announces Results for Its XILONIX™ Treatment of Non-Small Cell Lung Cancer (NSCLC)
5/16/2013 9:48:38 AM
More...
|
XBiotech USA, Inc. to Present at UBS Global Healthcare Conference
5/2/2013 6:16:43 AM
More...
|
XBiotech USA, Inc. Touts Positive Phase 2 Vascular Disease Results
11/21/2012 7:16:37 AM
More...
|
XBiotech USA, Inc. Reports Positive Phase II Interim Analysis Results From Type 2 Diabetes Study
10/29/2012 10:36:23 AM
More...
|
XBiotech USA, Inc. Announces Progress in Clinical Development of Treatment for Psoriasis
10/18/2012 1:07:00 PM
More...
|
XBiotech USA, Inc. Eyes $200 Million Campus in E. Austin, Can Potentially Employ Up to 2,000
8/30/2012 8:07:41 AM
More...
|
C3i Inc. to Provide Full-Service Technology Support and Oracle Clinical, Oracle Remote Data Capture Business Process Outsourcing to XBiotech, Inc.
6/2/2011 10:24:19 PM
More...
|